Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1957 2
1959 1
1960 1
1963 3
1964 3
1965 2
1967 1
1968 2
1969 3
1970 5
1971 5
1972 1
1973 6
1974 4
1975 5
1976 4
1978 5
1980 6
1981 1
1982 7
1983 2
1984 5
1985 2
1986 13
1987 6
1988 9
1989 11
1990 11
1991 11
1992 9
1993 9
1994 31
1995 28
1996 24
1997 24
1998 22
1999 20
2000 15
2001 15
2002 32
2003 31
2004 22
2005 25
2006 30
2007 36
2008 38
2009 31
2010 29
2011 33
2012 26
2013 31
2014 32
2015 29
2016 32
2017 29
2018 28
2019 31
2020 37
2021 43
2022 30
2023 38
2024 34
2025 22

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

988 results

Results by year

Filters applied: . Clear all
Page 1
The potential of Senolytics in transplantation.
Matsunaga T, Iske J, Schroeter A, Azuma H, Zhou H, Tullius SG. Matsunaga T, et al. Among authors: azuma h. Mech Ageing Dev. 2021 Dec;200:111582. doi: 10.1016/j.mad.2021.111582. Epub 2021 Oct 1. Mech Ageing Dev. 2021. PMID: 34606875 Free PMC article. Review.
The Impact of FGFR3 Alterations on the Tumor Microenvironment and the Efficacy of Immune Checkpoint Inhibitors in Bladder Cancer.
Komura K, Hirosuna K, Tokushige S, Tsujino T, Nishimura K, Ishida M, Hayashi T, Ura A, Ohno T, Yamazaki S, Nakamori K, Kinoshita S, Maenosono R, Ajiro M, Yoshikawa Y, Takai T, Tsutsumi T, Taniguchi K, Tanaka T, Takahara K, Konuma T, Inamoto T, Hirose Y, Ono F, Shiraishi Y, Yoshimi A, Azuma H. Komura K, et al. Among authors: azuma h. Mol Cancer. 2023 Nov 18;22(1):185. doi: 10.1186/s12943-023-01897-6. Mol Cancer. 2023. PMID: 37980528 Free PMC article.
Mechanistic insights into lethal hyper progressive disease induced by PD-L1 inhibitor in metastatic urothelial carcinoma.
Nishimura K, Takahara K, Komura K, Ishida M, Hirosuna K, Maenosono R, Ajiro M, Sakamoto M, Iwatsuki K, Nakajima Y, Tsujino T, Taniguchi K, Tanaka T, Inamoto T, Hirose Y, Ono F, Kondo Y, Yoshimi A, Azuma H. Nishimura K, et al. Among authors: azuma h. NPJ Precis Oncol. 2024 Sep 17;8(1):206. doi: 10.1038/s41698-024-00707-6. NPJ Precis Oncol. 2024. PMID: 39289546 Free PMC article.
Changes of T-cell Immunity Over a Lifetime.
Nian Y, Minami K, Maenesono R, Iske J, Yang J, Azuma H, ElKhal A, Tullius SG. Nian Y, et al. Among authors: azuma h. Transplantation. 2019 Nov;103(11):2227-2233. doi: 10.1097/TP.0000000000002786. Transplantation. 2019. PMID: 31107822 Free PMC article. Review.
Tertiary lymphoid structure and neutrophil-lymphocyte ratio coordinately predict outcome of pembrolizumab.
Komura K, Tokushige S, Ishida M, Hirosuna K, Yamazaki S, Nishimura K, Ajiro M, Ohno T, Nakamori K, Kinoshita S, Tsujino T, Maenosono R, Yoshikawa Y, Takai T, Tsutsumi T, Taniguchi K, Tanaka T, Takahara K, Inamoto T, Hirose Y, Ono F, Shiraishi Y, Yoshimi A, Azuma H. Komura K, et al. Among authors: azuma h. Cancer Sci. 2023 Dec;114(12):4622-4631. doi: 10.1111/cas.15976. Epub 2023 Sep 26. Cancer Sci. 2023. PMID: 37752769 Free PMC article.
First-line therapy for metastatic renal cell carcinoma: A propensity score-matched comparison of efficacy and safety.
Yanagisawa T, Mori K, Kawada T, Katayama S, Uchimoto T, Tsujino T, Nishimura K, Adachi T, Toyoda S, Nukaya T, Fukuokaya W, Urabe F, Murakami M, Yamanoi T, Bekku K, Komura K, Takahara K, Hashimoto T, Fujita K, Azuma H, Ohno Y, Shiroki R, Uemura H, Araki M, Kimura T; JK-FOOT study group. Yanagisawa T, et al. Among authors: azuma h. Urol Oncol. 2024 Nov;42(11):374.e21-374.e29. doi: 10.1016/j.urolonc.2024.06.013. Epub 2024 Jul 31. Urol Oncol. 2024. PMID: 39085019
Boron neutron capture therapy for urological cancers.
Takahara K, Miyatake SI, Azuma H, Shiroki R. Takahara K, et al. Among authors: azuma h. Int J Urol. 2022 Jul;29(7):610-616. doi: 10.1111/iju.14855. Epub 2022 Mar 3. Int J Urol. 2022. PMID: 35240726 Review.
Recall features and allorecognition in innate immunity.
Uehara H, Minami K, Quante M, Nian Y, Heinbokel T, Azuma H, Khal AE, Tullius SG. Uehara H, et al. Among authors: azuma h. Transpl Int. 2018 Jan;31(1):6-13. doi: 10.1111/tri.13073. Epub 2017 Oct 20. Transpl Int. 2018. PMID: 28926127 Free PMC article. Review.
988 results